Effects of AKT Inhibitors for PIK3CA/AKT1/PTEN-Altered Advanced or Metastatic Breast Cancer: A Meta-Analysis of Randomized Clinical Trials. de Moraes FCA, Sano VKT, Pereira CRM, de Laia EA, et al. Clin Breast Cancer 2025 Mar 20:S1526-8209(25)00079.

Read + Share

Amedeo Smart

Independent Medical Education